SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese population.
Saved in:
| Title: | SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese population. |
|---|---|
| Authors: | Fung LW; formerly, Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; formerly, Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China., Yan VK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Kwan C; Sau Po Centre of Ageing, The University of Hong Kong, Hong Kong SAR, China.; formerly, Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; formerly, Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China., Kwok WC; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China., Lam DC; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China., McDonald CF; Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Australia.; University of Melbourne, Parkville, Melbourne, Victoria, Australia.; Institute for Breathing and Sleep, Heidelberg, Melbourne, Victoria, Australia., Bloom CI; National Heart and Lung Institute, Imperial College London, London, UK., Wong IC; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China.; Aston Pharmacy School, Aston University, Birmingham, B4 7ET, UK.; Advanced Data Analytics for Medical Science (ADAMS) Limited, Hong Kong SAR, China., Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. ewchan@hku.hk.; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China. ewchan@hku.hk.; Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China. ewchan@hku.hk.; The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, China. ewchan@hku.hk. |
| Source: | BMC pulmonary medicine [BMC Pulm Med] 2024 May 14; Vol. 24 (1), pp. 232. Date of Electronic Publication: 2024 May 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2466 |
|---|---|
| DOI: | 10.1186/s12890-024-03038-1 |
